white blood cells, 49% neutrophils, 43% lymphocytes, 3% monocytes, and 1% bands. The patient received the hepatitis B vaccination (HBV) and hepatitis B immunoglobulin (HBIG). The hepatitis panel demo nstrated a positive hepatitis A virus immunoglobulin (Ig) G antibody sug gestive of maternal immunity and negative hepatitis A virus IgM antibody, hepatitis B surface antigen, hepatitis B surface antibody, hepatitis B core IgG antibody, and hepatitis C antibody. Syphilis IgG, blood culture, and HIV-1 and -2 enzyme-linked immunosorbent assay were negative. HIV-1 RNA assay was negative at birth and repeat HIV-1 DNA polymerase chain reaction at ∼1 month of age was also negative.
Discussion:
In the absence of maternal prenatal records, infant serology should be drawn for HIV, hepatitis B, hepatitis C, and syphilis. If the patient is presumed to be 1 to 2 days old, thought should be given to sepsis screening, particularly if the patient is symptomatic or appears to be premature on examination. [1] [2] [3] Unless there are clinical fi ndings concerning for rubella, infant screening is not useful. 4 Abandoned infants with unknown vaccination records should receive the HBV. If the infant is estimated to be <7 days old and maternal hepatitis B surface antigen is unknown, HBIG also should be administered as soon as possible. 5 Although erythromycin 0.5% ophthalmic ointment is most effective in preventing ophthalmia neonatorum if given in the fi rst 4 hours of life, there may be marginal benefi t up to 1 to 2 days of life. 6 Perinatal HIV screening is one of the most time-sensitive dilemmas of the evaluation of abandoned infants. Chemoprophylaxis for HIV is effective only if started within 48 hours of birth, and initiation of prophylaxis outside the 48-hour window of time in a neonate who has an established HIV infection may contribute to antiretroviral res istance. Therefore, abandoned infants known to be <48 hours old should have urgent HIV screening. Outside this 48-hour window of time, HIV screening is recommended but less urgent. The National Perinatal HIV Hotline (1-888-448-8765) is a readily available resource for HIV evaluation in infants. 7, 8 Infants may test positive for hepatitis B surface antigen for up to 1 to 2 weeks after receiving the HBV because of the antigen in the vaccine. Thus, a weakly positive hepatitis B surface antigen does not necessarily refl ect actual hepatitis B infection. 9 When maternal hepatitis B status is unknown, testing for hepatitis B surface antibody and antigen should take place at 9 to 18 months of age after maternal antibodies have diminished or 1 to 2 months after the completion of the HBV series. The fi rst HBV should be administered as soon as possible, followed by the second dose at least 4 weeks after the first dose. The third dose should be given at 6 months of age or older and at least 2 months after the second dose and 4 months after the first dose. 10 Although screening for hepatitis C is not routinely performed during prenatal care, mothers of abandoned infants may be at higher risk for this infection. 11, 12 Patients who test positive for hepatitis C antibodies should be retested at 9 to 18 months when maternal antibodies have waned or tested with hepatitis C virus RNA as early as 1 to 2 months of age to assess for active infection. 13 A positive syphilis screening test should refl exively initiate a treponemal test (Treponema pallidum [TP]-particle agglutination, fl uorescent treponemal antibody-absorption, TP-enzyme immunoassay, or microhemag glutination assay-TP). In cases of abandoned infants without documented maternal syphilis serology or treatment, the infant also should be evaluated with a CBCd, cerebro spinal fl uid (CSF) studies including CSF VDRL test, and consultation with an infectious disease specialist to discuss penicillin treatment regimen and further studies, including chest radiograph, long-bone radiographs, eye examination, and liver function tests.
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Question: What features of routine newborn care should be provided for abandoned infants?
Case Continuation: It was unknown whether the patient was born at a hospital. Even if he had received routine care, there was no way to connect him to his newborn screen card, hearing screen, or administered medications. The patient was given intramuscular vitamin K and had a newborn screen drawn that was normal. He had an otoacoustic emissions hearing screen and passed in both ears. Blood type was CPS, Child Protective Services; CRP, C-reactive protein; CXR, chest radiograph; EIA, enzyme immunoassay; FTA-ABS, fl uorescent treponemal antibodyabsorption; GBS, Group B streptococcus; IM, intramuscular;
LGA, large for gestational age; MHA, microhemagglutination assay; PA, particle agglutination; PCR, polymerase chain reaction; RPR, rapid plasma reagin; SGA, small for gestational age; SpO 2 , pulse oximetry.
A+ and direct Coombs was negative. Urine drug screen was negative and he never developed symptoms of withdrawal. He went home with an adoptive family and is growing and developing appropriately for age.
Discussion: One milligram of vitamin K given intramuscularly shortly after birth is routine practice for the care of neonates in the United States to prevent both classic and late-onset hemorrhagic disease of the newborn, also known as vitamin K defi ciency bleeding (VKDB). 16 Classic hemorrhagic disease of the newborn occurs from 1 to 7 days of life when a physiologic drop in vitamin K-dependent clotting factors occurs. This is thought to be due to poor vitamin K transfer across the placenta and a sterile gastrointestinal tract, not yet colonized with vitamin K-producing bacteria. It occurs in ∼2% of neonates who have not received vitamin K. 17 Late-onset VKDB occurs from 2 weeks to 6 months of age. Risk factors include exclusive breastfeeding, as breast milk has low vitamin K content (1-4 μg/L), and cholestasis, which prevents the absorption of fat-soluble vitamins. The incidence in exclusively breastfeeding infants is 4.4 to 7.2/100 000. 18 Abandoned neonates who are within the age range of classic VKDB (1-7 days) should be given 1 mg vitamin K intramuscularly because the risk of disease is reasonably high even for healthy children. The therapeutic index of vitamin K is relatively high, requiring 10 to 20 mg vitamin K to produce toxic effects, so abandoned neonates who may have already received vitamin K at birth will not be harmed by a repeat dose. 19 The incidence of late-onset VKDB is low even within the at-risk population of exclusively breastfed infants. Most abandoned neonates and infants will be fed formula that contains vitamin K, 50 μg/L. Therefore, vitamin K may not be necessary in children older than 2 weeks.
All abandoned infants should have newborn screening performed unless the results from previous screens are available. Ideally, newborn screens should be sent between 24 and 48 hours of life and 7 to 14 days of life, as reference ranges are specifi ed for these windows of time. Specimens can be sent for children up to 12 months of age; however, there may be higher false-positive or -negative results.
All abandoned infants should have either an otoacoustic emissions or auditory brainstem response hearing screen unless the results of a previous hearing screen are available. Early detection of hearing defi cits allows for early intervention and ideally prevents delays in child development.
Blood glucose screening should be performed in infants thought to be <24 hours old who are preterm, small for gestational age, or large for gestational age based on Ballard examination and growth percentiles. Also, patients of any age who have symptoms of hypoglycemia should have their blood sugar checked. Management of hypoglycemia should be continued based on nursery protocol. 20 Infants should be screened for jaundice on examination at initial evaluation. Because the infant's exact age will likely be unknown, the neonatal bilirubin nomograms will be less useful. Therefore, risk factors, including prematurity based on Ballard examination and direct Coombs, will be the primary tools used to decide on jaundice follow-up and initiation of phototherapy. 21 Drug screening is appropriate in abandoned neonates both for medical decision-making and legal purposes. Ideally, a urine drug screen, as well as an additional test that reflects exposure over the course of the pre gnancy, should be used and may include meconium, neonatal hair, or umbilical cord specimens. 22 Drug screening becomes particularly important in infants who screen positive for opiates because they should be observed for withdrawal symptoms. Positive drug screens also may have signifi cant legal implications if parents are prosecuted or attempt to regain custody of the infant.
Conclusions:
Abandoned infants <61 days old are a unique population that requires extra medical attention in addition to routine newborn care. The medical evaluation of an abandoned infant poses a challenge to health care professionals because they are rarely encountered, and although medical literature is rich with guidelines for routine prenatal and neonatal care, discussions in the context of infant abandonment are sparse. This article provides health care professionals an organized approach to the medical evaluation of abandoned infants (Table 2) . Further research should investigate the diagnoses made in cases of abandoned infants, as well as factors leading to infant abandonment. This information could provide greater clarity of the risks associated with infant abandonment.
